110
Participants
Start Date
August 19, 2021
Primary Completion Date
May 20, 2026
Study Completion Date
December 10, 2029
coformulation pembrolizumab/quavonlimab
Intravenous (IV) infusion
lenvatinib
Oral administration
MK-4830
IV infusion
coformulation favezelimab/pembrolizumab
IV infusion
R-DXd
IV Infusion
RECRUITING
Standort Penzing der Klinik Ottakring-Abteilung für Atemwegs-und Lungenkrankheiten ( Site 3101), Vienna
RECRUITING
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 3100), Vienna
COMPLETED
Westmead Hospital-Department of Medical Oncology ( Site 4004), Westmead
RECRUITING
Monash Health-Oncology Research ( Site 4005), Clayton
COMPLETED
The Prince Charles Hospital-Oncology Clinical Trials ( Site 4003), Brisbane
COMPLETED
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 3800), Szolnok
RECRUITING
Hollywood Private Hospital-Medical Oncology ( Site 4001), Perth
ACTIVE_NOT_RECRUITING
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 3502), Sankt Gallen
RECRUITING
Seoul National University Bundang Hospital-Medical Oncology ( Site 4104), Seongnam
COMPLETED
UPMC Hillman Cancer Center ( Site 0177), Pittsburgh
RECRUITING
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 3301), Rozzano
COMPLETED
Ospedale San Raffaele-Oncologia Medica ( Site 3303), Milan
RECRUITING
Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 3304), Milan
COMPLETED
MFSMC-HJWCI-Oncology Research ( Site 0178), Baltimore
RECRUITING
Virginia Cancer Institute ( Site 0169), Richmond
RECRUITING
Chungbuk National University Hospital ( Site 4106), Cheongju-si
COMPLETED
St Francis Cancer Center-Research Office ( Site 0167), Greenville
COMPLETED
Northside Hospital-Northside Hospital Oncology Network ( Site 0156), Atlanta
COMPLETED
Baptist Health Lexington-Research ( Site 0158), Lexington
COMPLETED
University of Kentucky Chandler Medical Center-Medical Oncology ( Site 0157), Lexington
COMPLETED
Cleveland Clinic-Taussig Cancer Center ( Site 0166), Cleveland
COMPLETED
Parkview Research Center at Parkview Regional Medical Center ( Site 0180), Fort Wayne
RECRUITING
ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 3300), Siena
COMPLETED
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0172), Omaha
COMPLETED
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0179), Omaha
COMPLETED
Banner MD Anderson Cancer Center ( Site 0152), Gilbert
COMPLETED
GBUZ LOKB-Oncology department #1 ( Site 3701), Saint Petersburg
COMPLETED
"GBUZ SPb CRPCstmc(o) ( Site 3705)", Saint Petersburg
COMPLETED
N.N.Petrov Research Institute of Oncology-Department of Chemotherapy and Innovative Technologies ( Site 3703), Saint Petersburg
COMPLETED
Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 3704), Saint Petersburg
COMPLETED
Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 3702), Saint Petersburg
COMPLETED
Krasnoyarsk Regional Oncology Dispensary, Named after Krizhanovsky ( Site 3708), Krasnoyarsk
RECRUITING
Rambam Health Care Campus-Oncology ( Site 3600), Haifa
RECRUITING
Meir Medical Center. ( Site 3601), Kfar Saba
RECRUITING
Rabin Medical Center-Oncology ( Site 3604), Petah Tikva
RECRUITING
Sheba Medical Center-ONCOLOGY ( Site 3603), Ramat Gan
RECRUITING
Shaare Zedek Medical Center-Oncology ( Site 3602), Jerusalem
COMPLETED
Cross Cancer Institute ( Site 3004), Edmonton
COMPLETED
Princess Margaret Cancer Centre ( Site 3003), Toronto
COMPLETED
St. Marys Hospital Center ( Site 3000), Montreal
RECRUITING
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 3900), Warsaw
COMPLETED
Warminsko-Mazurskie Centrum Chorob Płuc w Olsztynie ( Site 3903), Olsztyn
RECRUITING
Seoul National University Hospital ( Site 4101), Seoul
COMPLETED
Asan Medical Center-Lung Cancer Center ( Site 4103), Seoul
RECRUITING
Samsung Medical Center ( Site 4100), Seoul
RECRUITING
Instituto Catalan de Oncologia - Hospital Duran i Reynals ( Site 3403), L'Hospitalet de Llobregat
RECRUITING
Hospital Universitari Vall d'Hebron-Oncology ( Site 3401), Barcelona
RECRUITING
Hospital Clinic de Barcelona ( Site 3404), Barcelona
Collaborators (1)
Daiichi Sankyo
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY